Skip to main content
Log in

Secondary myelodysplastic syndrome after hydroxychloroquine therapy

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Primary myelodysplastic syndromes (MDS) occur in the absence of exposure to ionizing radiation, chemotherapeutic agents or myelotoxic drugs, whereas secondary MDS occurs in the presence of such exposure. We encountered 4 patients among 217 patients on hydroxychloroquine for rheumatological conditions in 2005 diagnosed with MDS. Two patients were male and two were female; the median age was 69.75 years, (range 65–76). The dose of hydroxychloroquine for all patients was 400 mg daily with median treatment duration of 10.5 years and a range of 6–16. All patients had bone marrow biopsy confirmation of the diagnosis of MDS. The incidence of MDS in a group older than 70 years ranges from 15 to 50/100,000 persons per year. The diagnosis of 4 cases of MDS among 217 patients in 1 year is approximately 123–137-fold higher than the risk of MDS in the general population aged more than 70 years (P < 0.001) and suggests that long-term treatment with hydroxychloroquine is associated with an increased risk of developing secondary MDS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fox RI (1993) Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 23(2 Suppl 1):82–91

    Article  PubMed  CAS  Google Scholar 

  2. Sole F, Espinet B, Sanz GF et al (2000) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol 108:346–356

    Article  PubMed  CAS  Google Scholar 

  3. Kerkhofs H, Hermans J, Haak HL, Leeksma CH (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 65:73–81

    PubMed  CAS  Google Scholar 

  4. Heaney ML, Golde DW (1999) Myelodysplasia. N Engl J Med 340:1649–1660

    Article  PubMed  CAS  Google Scholar 

  5. Hofmann WK, Koeffler HP (2005) Myelodysplastic syndrome. Annu Rev Med 56:1–16

    Article  PubMed  CAS  Google Scholar 

  6. Huebner G, Karthaus M, Pethig K, Freund M, Ganser A (2000) Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation. Transplantation 70:688–690

    Article  PubMed  CAS  Google Scholar 

  7. Renneboog B, Hansen V, Heimann P et al (1996) Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7. Br J Haematol 92:696–698

    Article  PubMed  CAS  Google Scholar 

  8. Steensma DP, Bennett JM (2006) The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc 81(1):104–130

    Article  PubMed  Google Scholar 

  9. Aul C, Germing U, Gattemann N et al (1998) Increasing incidence of myelodysplastic syndrome: real or fictitious? Leuk Res 22:93–100

    Article  PubMed  CAS  Google Scholar 

  10. MDS foundation (http://www.mds-foundation.org)

  11. Knipp S, Hildebrandt B, Richter G et al (2005) Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 90:691–693

    PubMed  Google Scholar 

  12. Agomo PU, Idigo JC, Afolabi BM (1992) “Antimalarial” medicinal plants and their impact on cell populations in various organs of mice. Afr J Med Med Sci 21(2):39–46

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hamed A. Daw.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muslimani, A.A., Spiro, T.P., Chaudhry, A.A. et al. Secondary myelodysplastic syndrome after hydroxychloroquine therapy. Ann Hematol 86, 531–534 (2007). https://doi.org/10.1007/s00277-006-0249-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0249-3

Keywords

Navigation